mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.5 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.5 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
0.028 |
0.5 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.5 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |